Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises $2.2M in Private Placement

NEW YORK (GenomeWeb News) – GeneNews has accepted subscriptions for a non-brokered private placement of common stock, raising C$2.3 million (US$2.2 million) in gross proceeds.

The amount raised surpasses the proceeds the firm expected to realize when it announced the direct placement two weeks ago. At that time, it said that it expected to raise C$2 million from the offering.

The Toronto-based molecular diagnostics firm said that it will issue an aggregate of 5,134,444 common shares at a price of C$.45 per share.

GeneNews said it will use the proceeds to support marketing initiatives for its ColonSentry test in Canada, the US, Europe, and Asia, and for pipeline development. The firm has already launched the test in Canada and expects to launch it soon in the other noted geographic areas.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.